# Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation

> **NCT02016976** · NA · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Pacemaker Implantation
- Pain

## Interventions

- **DRUG:** EMLA Analgesic Cream
- **DRUG:** Dormicum 2.5 mg and Pethidine 25 mg

## Key facts

- **NCT ID:** NCT02016976
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016976, "Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02016976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*